logo.gif (2253 bytes)



Home Page

Welcome

Committees

Sponsors

Advance Program

Posters Sessions:

General
Information

Pre and Post Congress Tours

Registered Accompanying Persons Program

Accommodation

Accommodation and Tour Form

Registration Form

 

ADVANCE PROGRAM - Poster Session

TUESDAY, OCTOBER 3, 2000

08:30 - 12:30 Poster Hall
P211:  INTERVENTIONAL CARDIOLOGY II
 Board No.  
1 EVALUATION OF DIRECT STENT IMPLANTATION WITHOUT PREDILATATION BY INTRAVASCULAR ULTRASOUND
J.M. de la Torre, J. Zueco, A. Figueroa, T. Colman, Santander, Spain
METHYLPREDNISOLONE COATED STENTS DECREASE NEOINTIMAL HYPERPLASIA IN A PORCINE CORONARY MODEL
I. De Scheerder, Y. Huang, Q.B. Ping, L. Wang, I. Vermeire, E. Verbeken, E. Schacht, Leuven, Belgium
TREATMENT OF BIFURCATION LESIONS USING CULOTTES STENTING: CLINICAL AND ANGIOGRAPHIC FOLLOW-UP
I. De Scheerder, J. Dens, W. Desmet, P. Coussement, J. Piessens, F. Van de Werf, Leuven, Belgium
THE EXANTRIC-CONSANTRIC LASER CATHETER FOR IN-STENT RESTENOSIS
E. Ilkay, I. Karaca, A.E. Kilicoglu, Y. Ozbay, M. Akbulut, N. Arslan, Elazig, Turkey
5 MECHANICAL ROTATIONAL ATHERECTOMY IS SAFE AND HIGHLY EFFECTIVE STRATEGY FOR DEBULKING CALCIFIED CORONARY PLAQUES IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION
V. Lal, M. DeGregorio, C. Narala, T. Schreiber, S. Kazziha, T. Davis, T. LaLonde, N. Vikraman, A. Ali, Detroit, MI, USA
6 TEN YEAR CLINICAL AND ANGIOGRAPHIC FOLLOW-UP OF THE CORONARY WALLSTENT
E. El Moktar, D. Carrie, M. Elbaz, P. Cantie, M. Andrieu, M. Delay, J. Puel,
Toulouse, France
7 FEMOROPOPLITEAL STENTING. RESULTS, INDICATIONS, CHOICE OF THE STENT
M. Henry, M. Amor, Z. Chati, I. Henry, K. Tzvetanov, C. Klonaris, Nancy, France
8 STENT SUPPORTED ANGIOPLASTY OF EXTRACRANIAL CAROTID ARTERIES IN HIGH RISK PATIENTS
M. Henry, C. Klonaris, M. Amor, I. Henry, S. Kownator, F. Luizy, B. Foliguet, K. Tzvetanov, Nancy, France
9 EMBOLIZATION OF ROTAFLOPPY WIRE, AN UNUSUAL COMPLICATION OF ROTATIONAL ATHERECTOMY
K.P. Madhusoodanan, S. Gamnerdsiri, P. White, Hartford CT, USA
10  SAFETY AND EFFICACY OF USING 6F GUIDING CATHETERS IN CORONARY STENTING
K. Ravi, J. Fox, C. Reimers, A. Kasatkin, S. Kanchithapatham, W. Sherman,
New York NY, USA

P212:

BASIC RESEARCH: MYOCARDIAL AND VASCULAR BIOLOGY
12 SILDENAFIL ENHANCES THE PLATELET ANTIAGGREGATORY ACTIVITY OF NITRIC OXIDE
F.M. Burslem, P. Ellis, Sandwich, UK
13 EFFECTS OF VASTATINS ON SEROTONIN-INDUCED CONTRACTION IN SWINE CORONARY ARTERIES
J. Quidgley, S. Moreta, M.J. Crespo, San Juan PR, USA
14 CARVEDILOL PRESERVES MITOCHONDRIAL FUNCTION IN AN EX-VIVO MODEL OF GLOBAL MYOCARDIAL ISCHEMIA
P.F. Monteiro, L.M. Gonçalves, A.J. Moreno, L.A. Providncia, Coimbra, Portugal
15 MODULATION OF CARVEDILOL ON CANINE CARDIAC CALCIUM-HANDLING PROTEIN EXPRESSION LEVEL
Y-F. Yang, M-J. Su, L-P. Lai, J-L. Lin, Taipei, Taiwan-R.O.C.
16 SYSTEMIC EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND FMS-LIKE TYROSINE KINASE-1 RECEPTOR IN ACUTE KAWASAKI DISEASE
K. Yasukawa, M. Terai, A.H. Rowley, T. Toyozaki, S.T. Shulman, Y. Kohno,
Chiba, Japan
17 THE HYDROLYSIS OF THE THROMBIN RECEPTOR PAR-1 IS ACCELERATED BY THE INTERACTION OF THE THROMBIN HEPARIN BINDING SITE WITH THE PLATELET GLYCOPROTEIN IB
E. De Candia, R. De Cristofaro, S. Rutella, R. Landolfi, Rome, Italy
18 PREVENTION OF CEREBRAL ANEURYSM FORMATION BY INHIBITION OF INDUCIBLE NITRIC OXIDE SYNTHASE
S. Fukuda, N. Hashimoto, H. Naritomi, I. Nagata, K. Nozaki, S. Kondo, H. Kikuchi, Osaka, Japan
19 VEREXPRESSION OF NEUROCELL ADHESION MOLECULE (CD 56) IN HIBERNATING MYOCARDIUM
T. Wild, K. Schmid, N. Serbecic, M.R. Mehrabi, A. Momeni, R. Seitelberger, R. Horvat, Vienna, Austria
20 EFFECT OF L-ARGININE ON INTIMAL PRELIFERATION AND EXPRESSION OF RELATED CELL CYCLE REGULATORY FACTORS AFTER VASCULAR BALLOON INJURY IN THE RATS
J. Zhang, X. Nie, Z. Huang, R. Iiu, Henan, China
P213: DIAGNOSTIC METHODS II
21 PRIMARY PREVENTION OF PREMATURE CAD BEYOND LDL CHOLESTEROL
K.O. Akosah, A. Schaper, P. Havlik, La Crosse WI, USA
22  THE EFFECT OF LEFT VENTRICULAR END-DIASTOLIC PRESSURE ON DISPERSION OF VENTRICULAR REPOLARIZATION
G. Bajraktari, F. Hima, G. Dragusha, B. Xhaxho, S. Qirko, Prishtina, Kosovo
23 THE "CARFEM" VASCULAR INDEX AS A PREDICTIVE VALUE FOR CORONARY ATHEROSCLEROSIS
P.J.M. Claessens, C.F.W. Claessens, M.M.T. Claessens, M.C.F. Claessens, J.E.J. Claessens, Antwerp, Belgium
24 CLINICAL EXPERIENCE WITH A FIRST GENERATION IMPLANTABLE LOOP RECORDER
H. Mieszczanska, B. Ibrahim, T.J. Cohen, Minedla, NY, USA
25 CORONARY ARTERY-PULMONARY ARTERY FISTULA: ASSESSMENT WITH INTRAVENOUS ELECTRON-BEAM COMPUTED TOMOGRAPHIC CORONARY ANGIOGRAPHY
M. Ogata, S. Yamakami, J. Toyama, M. Okamoto, M. Tsuda, T. Matsushita, Y. Murakami, K. Iwata, T. Tani, T. Yamada, M. Kajiguchi, H. Satsurai, M. Yoshimoto, Ichinomiya Aichi, Japan
 26 CLINICAL USEFULNESS OF THROMBUS PRECURSOR PROTEIN(TpP)TM IN THE DIAGNOSIS OF ISCHEMIC HEART DISEASE AND CHANGES OF TpPTM AFTER LOW-MOLECULAR WEIGHT HEPARIN THERAPY
K.S. Song, H.K. Kim, Q. Park, Seoul, South Korea
27 RESTING ELECTROCARDIOGRAM IN THE DISTURBANCE OF GLUCOSE METABOLISM
C.D. Carbonell, San Antonio TX, USA
28  TRENDS IN THE USE OF CARDIAC INVASIVE PROCEDURES
J.A. Goudevenos, A. Papathanasiou, L.K. Michalis, D. Nikas, P. Tsakas, D. Sideris, Ioannina, Greece
29 NONINVASIVE QUANTIFICATION OF CORONARY ARTERY CALZIUM IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA USING ELECTRON BEAM COMPUTER TOMOGRAPHY
K. Kostner, U. Hoffmann, K. Derfler, Vienna, Austria
30 SINUS OF VALSALVA ANEURYSM: AN UNUSUAL COMPLICATION
K.P. Madhusoodanan, S. Gamnerdsiri, R. Chamberlain, B.A. Clark, Hartford CT, USA
31 TO STING OR NOT TO STING? A STUDY INTO THE WARMING OF LOCAL ANAESTHETIC PRIOR TO INSERTION
S.A. Noonan, A.M. Hill, A. Short, M.B. Buchalter, Cardiff, UK
32 INTRAVASCULAR ULTRASOUND (IVUS) AND CLINICAL CHARACTERISTICS IN LEFT MAIN CORONARY ARTERY (LMCA) STENOSIS
S. Jia, Y. Zhang, D. Hu, T. Li, M. Yang, L. Wang, F. Chen, Beijing, China
P214: ACUTE MYOCARDIAL INFARCTION II
33 RELATIONSHIP BETWEEN MEAN PLATELET VOLUME AND EARLY-PHASE COMPLICATIONS IN ACUTE MYOCARDIAL INFARCTION
M. Acikel, M.K. Erol, E. Bozkurt, N. Alp, H. Senocak, Ankara, Turkey
34  IS ACUTE MI MOST COMMON IN YOUNG ADULTS?
K.O. Akosah, A. Schaper, La Crosse WI, USA
35  ELECTROCARDIOGRAPHIC CRITERIA FOR PREDICTION OF INFARCT RELATED ARTERY AND ITS LESION SITE IN ACUTE INFERIOR WALL MYOCARDIAL INFARCTION
G. Kabakci, L. Yildiran, M.K. Batur, R. Cagrikul, O. Onalan, A. Yildirir, T. Acil, L. Tokgozoglu, F. Ozmen, S. Kes, Ankara, Turkey
36 VARIABILITY OF MYOCARDIUM AT RISK FOR ACUTE MYOCARDIAL INFARCTION
K.W. Klarich, T.F. Christian, S.T. Higano, R.J. Gibbons, Rochester MN, USA
37 SIGNIFICANCE AND PREVALENCE OF EKG SIGNS OF ACUTE RIGHT VENTRICLE MYOCARDIAL INFARCTION MIMICING ACUTE ANTERIOR INFARCTION
G. Koracevic, V. Erakovic, V. Nikolic, B. Stankovic, S. Andrejevic, M. Burazor, L. Todorovic, M. Tomasevic, S. Apostolovic, Nis, Yugoslavia
38 ACUTE RIGHT VENTRICLE MYOCARDIAL INFARCTION "IN EXTENSION": PREVALENCE, CLINICAL CHARACTERISTICS AND PROGNOSIS
G. Koracevic, V. Erakovic, B. Stankovic, V. Nikolic, S. Andrejevic, Z. Perisic, Z. Cirovic, S. Nagorni, M. Radosavljevic, Nis, Yugoslavia
39 THE INFLUENCE OF THE LUNAR CYCLE ON THE INCIDENCE OF ACUTE MYOCARDIAL INFARCTION IN POSTMENOPAUSAL WOMEN
T. Nakamura, T. Kono, H. Morita, A. Fujiwara, H. Onaka, Y. Kitaura, Osaka, Japan
40 ISCHEMICAL DISEASE IN CORONARY UNIT OF HOSPITAL IN PANCEVO DURING NATO AGGRESSION ON YUGOSLAVIA
Z. Pekmezovic, D. Grbic, R. Surbat, M. Vazic, M. Ristic, G. Veljovic, Belgrade, Yugoslavia
41 COMBINED LEUKOCYTE AND ERYTHROCYTE AGGREGATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
I. Shapira, R. Rothstein, D. Zeltser, R. Fusman, B. Gluzman, V. Prochorov, A. Roth, G. Keren, D. Avitzour, N. Arber, S. Berliner, Tel Aviv, Israel
42 PATIENTS' INTERPRETATION OF SYMPTOMS AS A CAUSE OF DELAY TO REACH HOSPITAL IN ACUTE MYOCARDIAL INFARCTION
R. Horne, D. James, J. Weinman, R. Vincent, Brighton, UK
43  ACUTE MYOCARDIAL INFARCTION IN DIABETIC AND NON-DIABETIC PATIENTS: CLINICAL PROFILE, MANAGEMENT AND IN-HOSPITAL COURSE
S.M. Macin, E.R. Perna, M.N. Augier, M.A. Aguero, N.G. Rios, J.R. Badaracco, Corrientes, Argentina
44 DIFFERENCES AMONG DIABETIC AND NON-DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
S.M. Macin, E.R. Perna, M.N. Augier, M.A. Aguero, N.G. Rios, J.R. Badaracco, Corrientes, Argentina
45 FIBRIN DEGRADATION PRODUCTS IN ACUTE MYOCARDIAL INFARCTION
E. Siniorakis, C. Brinias, P. Tsonou, I. Petsa-Ciubotariu, K. Patris, S. Arvanitakis, P. Bonoris, Athens, Greece
  62 MYOCARDIAL INFARCTION IN VERY YOUNG (<30 YEARS) AND IN VERY ELDERLY (>70 YEARS) PATIENTS
Murat Gencbay, Kenan Sonmez, Recep Demirbag, Muzaffer Degertekin, Fikret Turan, Istanbul, Turkey
P215: ELECTROCARDIOLOGY AND ELECTROPHYSIOLOGY
46 SIGNIFICANCE OF NORMALIZATION OF NEGATIVE T WAVES DURING THE CHRONIC PHASE OF ANTERIOR WALL ACUTE MYOCARDIAL INFARCTION
A. Tamura, T. Hazuku, K. Nagase, M. Nasu, Oita, Japan
47  HOLTER MONITORING IN CAD PATIENTS OPERATED FOR ABDOMINAL AORTIC ANEURYSM AND/OR AORTO-ILIAC OCCLUSION
J. Kawinski, J.K. Wranicz, I. Cygankiewicz, J. Bandurka, H. Bolinska, A. Sotysiak,
Lodz, Poland
48 THE SPIRONOLACTONE TEST
G. Lupescu, G. Lupescu, Jr., E. Perciun, Tg-Jiu, Romania
49 PROGNOSTIC IMPORTANCE OF DIFFERENT HOLTER VARIABLES IN SURVIVORS OF FIRST ACUTE MYOCARDIAL INFARCTION: 10 TO 12 YEARS OF FOLLOW-UP
A. Vittrup, A. Johansen, M. Moller, H. Mickley, Odense, Denmark
50 QT DISPERSION AFTER ACUTE MYOCARDIAL INFARCTION: ITS CORRELATION WITH HEART RATE VARIABILITY
J. Hitender, R. Avasthi, M.A. Albornoz, J.M. Greenblatt, W.S. Paine,
Clifton Heights PA, USA
51 THE DYNAMICS OF QTc DISPERSION PREDICTS REPERFUSION ARRYTHMIA IN ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH STREPTOKINASE
I. Balla, N. Kuka, A. Gace, D.A. Poci Kondili, Tirana, Albania
52 EFFECT OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY ON QT DISPERSION IN CORONARY ARTERIES WITH TOTAL AND SUBTOTAL OCCLUSION
A. Sagcan, L.H. Can, S. Payzin, A. Altintg, H. Kultursay, Izmir, Turkey
53 EFFECT OF SUCCESSFUL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY AND CORONARY STENTING ON LEFT VENTRICULAR DIASTOLIC FUNCTION AND QT DISPERSION
A. Sagcan, T. Karacoban, L.H. Can, S. Payzin, A. Altintig, H. Kultursay, Izmir, Turkey
60 INCIDENCE OF CORONARY ARTERY DISEASE IN THROMBOANGITIS OBLITERANS. THE CONTRIBUTION OF THE SYMPATHETIC OUTFLOW
I. Moyssakis, N. Dellis, I. Hallak, V. Votteas, D. Drosos, M. Kyriakidis, E. Bastounis, Athens, Greece
P216: COMPUTER APPLICATIONS
54 CONTINUUM OF RISK EVALUATION (CORE): BRIDGING WOSCOPS AND CARE
J. Caro, W.S. Klittich, K.F. Huybrechts, CORE Study Group Concord MA, USA
55 EXPLORING THE WEB CAUSATION OF CORONARY HEART DISEASE, IN GREECE: A MULTI-CENTER EPIDEMIOLOGICAL STUDY DESIGN BASED ON METHODOLOGICAL PROCEDURES AND META-ANALYSIS
D.B. Panagiotakos, C.C. Pitsavos, C.A. Chrysochoou, C.A. Stefanadis, P.K. Toutouzas, Glyfada, Greece
56 REMOTE CARDIAC CONSULTATION USING HYBRID BROADBAND TECHNOLOGY
S-T. Cheung, K. Smith, R.F. Davies, S.A. Kearns, R. Marsh, W.J. Keon, Ottawa, Canada
57 COMPUTERIZED INTERACTIVE DATABASE AND REPORTING SYSTEM FOR THE CATH LAB
J. Gallimidi, Haifa, Israel
P217: HEART FAILURE AND SYSTEMIC EFFECTS
58 ROLE OF CYTOKINES IN THE PATHOPHYSIOLOGY OF CARDIAC CACHEXIA
G. Filippatos, K. Tsilias, J. Koutras, D.D. Manolatos, D. Economou, L. Flessas, D. Kardara, L. Anthopoulos, G. Baltopoulos, F. Kardaras, Athens, Greece
59 STABILITY OF ACTIVATED FACTOR XII CONCENTRATION IN BLOOD SAMPLES
C. Westby, A. Solinski, R. Ford, Oslo, Norway
14:00 - 17:30 Poster Hall
P221: ELECTROCARDIOLOGY AND ELECTROPHYSIOLOGY II
1 DOES HEMODIALYSIS IN END-STAGE RENAL DISEASE AMELIORATE ARRHYTHMIC SUBSTRATE
G. Kazianis, H. Toumanidis, M. Karpathiotakis, A. Economou, Athens, Greece
2 DOES THE QRS-COMPLEX INDICATE THE LEFT VENTRICULAR SYSFUNCTION IN THE PRESENCE OF LEFT BUNDLE BRANCH BLOCK?
S. Myftiu, V. Paparisto, A. Goda, T. Goda, S. Qirki, Tirana, Albania
3 EFFECT OF CORONARY ANGIOPLASTY ON QT DISPERSION IN CORONARY ARTERY DISEASE
B. Sredniawa, A. Musialik-Lydka, S. Pasyk, Zabrze, Poland
4 RELATIONS OF QT DISPERSION WITH INFARCT SIZE AND LEFT VENTRICULAR WALL MOTION IN HEALING OF ANTERIOR WALL ACUTE MYOCARDIAL INFARCTION
A. Tamura, K. Nagase, Y. MIkuriya, M. Nasu, Oita, Japan
P222: INTERVENTIONAL CARDIOLOGY III 
PERCUTANEOUS REVASCULARIZATION IN PATIENTS WITH SEVERE LEFT VENTRICULAR DYSFUNCTION: DIRECT STENTING AS A SAFE APPROACH
J.M. de la Torre, J. Zueco, A. Figueroa, T. Colman, Santander, Spain
IMMEDIATE RESULTS OF DIRECT CORONARY STENTING
D.G. Iosseliani, A.V. Arablinski, I.H. Pozharov, Moscow, Russia
TACKLING CHALLENGING ANATOMIES: ACE BALLOON FACILITATED STENT PASSAGE USING THE "PUSH-PULL" ANGIOPLASTY TECHNIQUE
B.H. Lowell, Morristown, NJ, USA
EFFICACY AND SAFETY OF ASPIRIN ALONE VERSUS COUMADIN PLUS ASPIRIN AFTER PROVISIONAL HIGH-PRESSURE CORONARY STENTING
A. Machraoui, A. Germing, S. Dryander, S. Lange, D. Jaeger, B. Lemke, Flensburg, Germany
DIRECT CORONARY STENTING IN ANGIOGRAPHICALLY APPARENT THROMBUS CONTAINING LESIONS
T. Timurkaynak, M. Ozdemir, M. Cemri, R. Yalcin, B. Boyaci, A. Cengel, O. Dortlemez, Ankara, Turkey
10  EARLY AND MID-TERM CLINICAL AND ANGIOGRAPHIC OUTCOME AFTER CORONARY STENTING IN WOMEN
O. Badak, O. Goldeli, S. Guneri, O. Kirimli, O. Aslan, V. Keskin, U. Tekin, M. Ozdamar, V. Ozturk, Izmir, Turkey
59  HEPARIN-COATED STENT IMPLANTATION IN CHRONIC TOTAL OCCLUSION
M. Degertekin, K. Sonmez, M. Gencbay, N. Eksiduran, F. Turan, Istanbul, Turkey
60

LONG-TERM FOLLOW-UP OF LESION RELATED SIDE BRANCHES AFTER CORONARY STENTING: COMPARISON OF COIL AND TUBULAR DESIGN CORONARY STENTS
Murat Gencbay, Kenan Sonmez, Muzaffer Degertekin, Fikret Turan, Istanbul, Turkey

61  LONG TERM (5 YEAR) OUTCOMES OF WIKTOR STENT IMPLANTATIONS
Kenan Sonmez, Murat Gencbay, Ahmet Yilmaz, Ahmet Akcay, Muzaffer Degertekin, Niluer E Duran, Fikret Turan, Istanbul, Turkey
P223: LIPIDS AND LIPID METABOLISM I
11 ACUTE CORONARY SYNDROME IN YOUNG ADULTS WITH LOW LDL: HIGH RISK PATIENTS NOT IDENTIFIED BY CURRENT GUIDELINES
K.O. Akosah, A. Schaper, P. Havlik, La Crosse WI, USA
12 ACUTE INCREASE IN PLATELET AGGREGATION FOLLOWING HIGH FAT MEAL
V. Lal, A. Ali, J. Formolo, H. Rosman, T. LaLonde, N. Vikraman, Detroit MI, USA
13  CORONARY CALCIFICATION AND CORONARY ARTERY DISEASE: SITE BY SITE MORPHOLOGIC COMPARISON OF SPIRAL COMPUTED TOMOGRAPHY AND CORONARY ANGIOGRAPHY
M. Baltali, O. Barutcu, M.E. Korkmaz, I.H. Muderrisoglu, B. Ozin, F. Yalcin, S. Topcu, Adana, Turkey
14  ENHANCED FORMATION OF REACTIVE OXYGEN SPECIES IN HYPERCHOLESTEROLEMIA IS SUPPRESSED BY VARIOUS STATINS
B. Fink, E.L. Bassenge, Freiburg, Germany
15 HYPERCHOLESTEROLAEMIA AND DIABETES MELLITUS ARE PREDICTORS OF LOW HEART RATE VARIABILITY IN PATIENTS WITH AN ACUTE MYOCARDIAL INFARCTION
I. Karabinos, S. Koulouris, A. Kranidis, A. Paraskevopoulos, G. Makris, I. Lekatsas, I. Moshovitis, I. Koutras, T. Giannoulis, F. Symeonidis, N. Exadaktylos, Athens, Greece
16  COADMINISTRATION OF SIMVASTATIN AND EZETIMIBE LEADS TO SIGNIFICANT REDUCTION IN LDL-CHOLESTEROL
T. Kosoglou, I. Meyer, B. Musiol, D.L. Cutler, B. Yang, E.P. Veltri, M.B. Affrime, Kenilworth NJ, USA
17 LIPID LOWERING POTENTIAL OF MICRONISED FENOFIBRATE IN GENERAL PRACTICE
A. Steinmetz, H. Schmitz, P. Weltzien, Bonn, Germany
P224: ANGINA PECTORIS AND ACUTE CORONARY SYNDROMES I
18 COMPARATIVE EFFECT OF NIFEDIPINE AND CORVATONE IN A LONG DURATION AND TREATMENT OF THE PATIENTS WITH STABLE ANGINA PECTORIS HEART FAILURE WITH PACEMAKER
M. Bakhshiev, S. Golitsin, Y. Belenkov, Moscow, Russia
19 EFFECT OF PROSTAGLANDIN E1 ON PLASMA CHOLESTEROL LEVEL AND RED BLOOD CELL RHEOLOGY IN PATIENTS WITH STABLE ANGINA
E.E. Konstantinova, I.L. Polonetsky, Minsk, Belarus
20 EFFECT OF PROSTAGLANDIN E1 ON MICROCIRCULATION IN PATIENTS WITH STABLE ANGINA
E.E. Konstantinova, I.L. Polonetsky, L.Z. Polonetsky, V.G. Tsapaev, Minsk, Belarus
21  POSSIBILITIES OF MAGNETOCARDIOGRAPHY IN CORONARY ARTERY DISEASE DETECTION IN PATIENTS WITH NORMAL OR UNSPECIFICALLY CHANGED ECG
I.A. Chaikovsky, T. Hecker, B. Heiler, S.A. Eisernitz, J. Kohler, V.N. Sosnitsky, F.W. Steinberg, Essen, Germany
22 MAST CELL TRYPTASE: A NEW INFLAMMATORY MARKER IN STABLE CORONARY ARTERY DISEASE
E.N. Deliargyris, G.J. Dehmer, S.C. Smith Jr., T.C. Theoharides, Boston MA, USA
23 PSYCHOLOGICAL ASSESSMENT, CLINICAL CHARACTERISTICS AND PROGNOSIS IN X SYNDROME AFFECTED PATIENTS
A. Madureri, M. Metra, E. Vizzardi, T. Bordonali, L. Guarnieri, P. Cacciani, E. Sacchetti, S. Nodari, L. Dei Cas, Brescia, Italy
24 PSYCHIATRIC SYMPTOMS IN X SYNDROME AFFECTED PATIENTS
A. Madureri, M. Metra, E. Vizzardi, T. Bordonali, L. Guarnieri, P. Cacciani, E. Sacchetti, S. Nodari, L. Dei Cas, Brescia, Italy
25 LONG-TERM FOLLOW UP OF AMLODIPINE IN THE TREATMENT OF PATIENTS WITH STABLE ANGINA PECTORIS
J.R. Zhu, Y.S. Lin, Shanhai, China
P225: HYPERTENSION, VENTRICULAR HYPERTROPHY
26 ASSESSMENT OF HYPERTENSION BY USING AMBULATORY BLOOD PRESSURE MONITORS I: LOAD VALUES FOR AMBULATORY PULSE PRESSURE IN NORMOTENSIVE VS. HYPERTENSIVE
M. Ceyhan, U. Hodoglugil, M. Cemri, D. Barlas, H. Dortlemez, M.H. Smolensky, H. Zengil, Ankara, Turkey, Houston TX, USA
27 ASSESSMENT OF HYPERTENSION BY USING AMBULATORY BLOOD PRESSURE MONITORS II: LOAD VALUES FOR AMBULATORY DOUBLE PRODUCT IN NORMOTENSIVE VS. HYPERTENSIVE
M. Cemri, U. Hodoglugil, M. Ceyhan, D. Barlas, O. Dortlemez, M.H. Smolensky, H. Zengil, Ankara, Turkey, Houston TX, USA
28 AGE RELATED INCREASE OF LEFT VENTRICULAR MASS IN HYPERTENSIVE WOMEN
N. Hatzis, N. Sfougaris, B.A. Krokos, D. Stamatis, A. Sideris, E. Sioras, N. Prosmiti, S. Xydonas, D. Balatsouras, D. Kardara, F. Kardaras, Athens, Greece
29 CAROTID ATHEROSCLEROSIS AND THE RISK OF CEREBROVASCULAR ACCIDENT IN HYPERTENSIVE ELDERLY PATIENTS
K. Sakai, J-D. Lee, H. Shimizu, H. Uzui, T. Sugiyama, T. Ueda, S. Abe, Fukui, Japan
30 INTERACTION BETWEEN NITRIC OXIDE AND ANGIOTENSION CONVERTING ENZYME IN ESSENTIAL HYPERTENSION
E. Serdaroglu, A. Aydemir, O. Donma, Istanbul, Turkey
31 AWARENESS AND CONTROL OF HYPERTENSION IN PATIENTS WITH CORONARY ARTERY DISEASE - POLISH HYPERTENSION SURVEY
R. Szczech, K. Narkiewicz, L. Bieniaszewski, A. Kosmol, B. Krupa-Wojciechowska, Gdansk, Poland
32 INFLUENCE OF AGE AND ARTERIAL BLOOD PRESSURE (BP) VALUES ON ANTI-HYPERTENSIVE ACTION OF DIHYDROPYRIDINE COMPOUNDS
M. Velasco, M. de la Parte, M. Bermudez, E. Lezama, A. Luchsinger, F. Contreras, Caracas, Venezuela
33 THE IMMUNOCORRECTIVE EFFECT OF DIROTON IN ESSENTIAL HYPERTENSION
I.G. Alizade, N.T. Aliyeva-Karayeva, Baku, Azerbaijan
34 PROTECTIVE EFFECT OF LEFT VENTRICULAR HYPERTROPHY IN RIGHT CORONARY ARTERY OCCLUSIONS
C.A.M. Gottschall, M. de Freitas Gomes, Porto Alegre RS, Brazil
35 QTC INTERVAL DISPERSION IN DIFFERENT GEOMETRIC PATTERNS OF THE LEFT VENTRICLE IN SYSTEMIC ARTERIAL HYPERTENSION
F.E. Guerra, M. Guevara, C. Gutierrez, Maturin, Venezuela
36 HYPERTENSION MANAGEMENT IN GENERAL PRACTICE: THE SPHYGMO PROJECT
A. Zaninelli, E. Cofrancesco, G.F. Parati, A. Filippi, B. Francucci, E. Agabiti Rosei, G. Bettoncelli, M. Cortellaro, G. Mancia, Romano di Lombardia, Ital
P226: MYOCARDIAL VIABILITY, PRECONDITIONING, STUNNING AND PRESERVATION
37 CORRELATION OF CORONARY ARTERIES INTIMAL THICKENESS WITH PLASMA ENDOTHELIN-1 LEVELS IN PATIENTS SYNDROME-X
S.G. Deftereos, E.K. Karvouni, G.A. Lazaros, M. Foukarakis, N.M. Kouvousis, E.I. Rentoukas, J. Giannouleas, P. Zavitsanakis, A. Theodorakis, A.A. Zacharoulis, Athens, Greece
38 INCREASED PLASMA ADRENOMEDULLIN IN PATIENTS UNDERGOING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
M.K. Erol, Y. Genc, A. Kiziltunc, H. Senocak, E. Bozkurt, M. Acikel, M. Yilmaz, Erzurum, Turkey
39 DIGITALIS-LIKE IMMUNOREACTIVE SUBSTANCES (DLIS) IN MYOCARDIAL REMODELING
T. Hayashi, Y. Ijiri, H. Shimomura, F. Terasaki, Y. Kitaura, Takatsuki, Japan
40 QT DISPERSION AND MYOCARDIAL VIABILITY
P. Jarski, B. Sredniawa, A. Musialik-Lydka, S. Pasyk, Zabrze, Poland
41 A KATP CHANNEL OPENER NICORANDIL REDUCES QT DISPERSION DURING CORONARY ANGIOPLASTY
T. Kato, Y. Maruyama, T. Kamiyama, S. Tanaka, N. Yoshimoto, Saitama, Japan
42 FREE RADICALS METABOLITES INHIBIT CREATINE PHOSPHOKINASE (CPK) IN SERA OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
G. Koracevic, V. Cosic, S. Andrejevic, V. Djordjevic, T. Jevtovic, Nis, Yugoslavia
43 DO DIABETICS RECEIVING GLIBENCLAMIDE EXHIBIT ISCHEMIC PRECONDITIONING?
E. Rentoukas, S.G. Deftereos, G.A. Lazaros, M.G. Foukarakis, N. Kouvousis, E.K. Karvouni, E. Papaliberi, A. Zacharoulis, Athens, Greece
44 BLOOD CARDIOPLEGIA VERSUS ST.THOMAS`HOSPITAL CARDIOPLEGIA:ARE THE PERIOPERATIVE MYOCARDIAL EXTRACTIONS OF LACTATE, NORADRENALINE AND NEUROPEPTIDE Y USEFULL PARAMETERS TO DETERMINE A LOW CARDIAC OUTPUT SYNDROME IN PATIENTS AFTER CABG
U. Weisse, F. Isgro, A. Lehmann, W. Saggau, Ludwigshafen/Rhein, Germany
45 EFFECTS OF DIFFERENT ANTI-AGING DIETARY RESTRICTIONS ON ENDOTHELIN-1 RECEPTORS IN RAT LUNG
S. Del Ry, G. Cavallini, R.L. Vitale, A. Clerico, E. Bergamini, D. Giannessi, Pisa, Italy
46 HEAT SHOCK PROTEINS AFTER CARDIOPLEGIC ARREST AND REPERFUSION IN A SWINE MODEL OF CARDIAC SURGERYD. Giannessi, R.L. Vitale, C. Caselli, S. Del Ry, F. Bernini, S. Burchielli, D. Magnozzi, G. Taddei, F. Viglione, A. Virgone, M.G. Trivella, Pisa, Italy
47 HEAT SHOCK PROTEINS (HSP72, HSP70, HSP60, HSP27) FOLLOWING CARDIOPLEGIC ARREST IN HUMAN HEARTS
D. Giannessi, R.L. Vitale, C. Caselli, S. Del Ry, M.G. Andreassi, B. Formichi, B. Murzi, F. Santoli, V. Vanini, A. Biagini, Pisa, Italy
48 RELATION BETWEEN 201-TL UPTAKE AND MYOCARDIAL UNIPOLAR VOLTAGE
POTENTIALS DETERMINED BY ELECTROANATOMICAL MAPPING IN VIABILITY
ASSESSMENT
M. Gyvngyvsi, H. Sochor, A. Khorsand, D. Glogar, Vienna, Austria
49 EFFICIENCY OF DIFFERENT KINDS OF METABOLIC THERAPY WITH PREDUCTAL AND AMINOACIDS IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE
R.M. Zaslavskaya, E.S. Kelimberdieva, M. Teibloom, Moscow, Russia
 62 VALUE OF QT DISPERSION VARIATION IN DIAGNOSING
CORONARY ARTERY DISEASE AND IN DETECTING VIABLE TISSUE AFTER MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PHARMACOLOGICAL STRESS TEST
Bulent Mutlu, Onur Demirkol, Cem Ermeydan, Yelda Baþaran, Istanbul, Turkey
P227: LIPIDS AND LIPID METABOLISM II
50 ATORVASTATIN, LIPID PEROXIDATION AND TOTAL ANTIOXIDANT STATUS
A. Aydemir, F. Borlu, E. Serdaroglu, I. Demir, T. Konduk, O. Donma, Istanbul, Turkey
51 THE RELATIONSHIP BETWEEN FIBRINOGEN AND CORONARY ARTERY DISEASE IN TURKISH INDIVIDUALS
M. Baltali, M.E. Korkmaz, I.H. Muderrisoglu, B. Ozin, R. Anarat, S. Topcu, F. Yalcin, Adana, Turkey
 52  ASSOCIATION OF CORONARY ATHEROSCLEROSIS WITH METABOLISM OF SATURATED AND POLYUNSATURATED FATTY ACIDS
V. Blaha, D. Solichova, D. Cernohorska, R. Hyspler, P. Vyroubal, Z. Zadak, Hradec Kralove, Czech Republic
53 DO STATINS IMPROVE PLATELET FUNCTIONS INDEPENDENT OF THE THEIR LIPID LOWERING EFFECT?
C. Ceyhan, E. Ercan, M. Zoghi, M. Kayikcyodlu, A. Akylly, C. Turkoglu, M. Akyn,
Izmir, Turkey
54  EFFECTS OF LIPID LOWERING DRUG THERAPY WITH ATORVASTATIN IN PATIENTS WITH HIGH HYPERCHOLESTEROLEMIA AND CORONARY ARTERY DISEASE
N.N. Kipshidze, S.D. Chumburidze, K.A. Nadaraia, Tbilisi, Georgia
55 CORONARY ARTERY DISEASE PATIENTS WITH VERY LOW BLOOD CHOLESTEROL LEVEL: POLYCYTHEMIA VERA.
G.N. Gorokhovskaya, E. Peresechenski, T.I. Torkhovskaya, A.I. Martynov, E.S. Fortinskaya, V.V. Soboleva, V.A. Sergueev, E.M. Khalilov
56 THE EFFECT OF ATORVASTATIN ON ACTIVATED FACTOR XII, FIBRINOGEN AND LIPID PROFILE
J. Dick, M. McClaren, R. Ford, C. Westby, Oslo, Norway
57 THE EFFECT OF TICLOPIDINE ON PLATELET AGGREGATION IN PATIENTS UNDERGOING SUCCESSFUL CORONARY STENING
A. Sagcan, S.B. Omay, M. Akin, Izmir, Turkey
58 DOES SPONTANEOUS SERUM CHOLESTEROL REDUCTION IN ACUTE MYOCARDIAL INFARCTION ASSOCIATE WITH MORE IN-HOSPITAL COMPLICATIONS? EXPERIENCE IN 197 PATIENTS
K.G. Adamian, A.V. Astvatsatrian, A.L. Chilingarian, A.Z. Garibjanian, T.R. Astvatsatrian, S.I. Vardanian, Yerevan, Armenia
62 LIPID PROFILE IN ISCHEMIC HEART DISEASES
A. Aydin, M. Tokac, M. Yazici, G. Danis, A. Icli, K. Ozdemir, B. Korkut, H. Gok,
Konya, Turkey
   


This site was developed by .